Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall
MedSun: Newsletter #47, April 2010

FDA MedWatch Safety Alert

FDA and Baxter notified healthcare professionals of a Class I recall of the HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems, which are prescription medical devices used to treat pediatric and adult patients with kidney failure. Reports of serious injuries and at least one death have been associated with increased Intraperitoneal Volume (IIPV), also known as overfill of the abdominal cavity. IIPV may result in serious injury or death from conditions including but not limited to: abdominal wall and/or diaphragmatic hernias, hydrothorax, heart failure, acute hypertension, and others.

Additional Information:

FDA MedWatch Safety Alert. Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall. March 3, 2010.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm202885.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun